ECYT
Endocyte, Inc.

4,756
Loading...
Loading...
Endocyte, Inc. engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN.
Sector:
Health Technology
Industry:
Biotechnology
Employees:

Frequently Asked Questions

What is Market Cap of Endocyte, Inc.?
What is the 52-week high for Endocyte, Inc.?
What is the 52-week low for Endocyte, Inc.?
What is Endocyte, Inc. stock price today?
What was Endocyte, Inc. stock price yesterday?
What is the PE ratio of Endocyte, Inc.?
What is the Price-to-Book ratio of Endocyte, Inc.?
What is Endocyte, Inc.'s EBITDA?
What is the 50-day moving average of Endocyte, Inc.?
How many employess does Endocyte, Inc. has?

Latest ECYT News

View
No ECYT news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.